2017
DOI: 10.15171/ijb.1505
|View full text |Cite
|
Sign up to set email alerts
|

Expression Profi ling of Hspb1 and Tp53 Genes through RT-qPCR in Different Cancer Types of Canis familiaris

Abstract: Background: Diagnostic molecular marker studies are in vogue to have insight of most prevalent animal diseases including cancer. Objectives: Gene expression profi ling of pro and anti-apoptotic genes was conducted in dog Lymphoma, CTVT, SCC, granuloma, perianal adenocarcinoma and mammary tumors. Materials and Methods: Cancerous tissues of 21 aff ected animals were obtained. Total RNA was extracted followed by cDNA synthesis. Comparative Ct method via Taqman assay (RT-qPCR) was used to quantify corresponding mR… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 35 publications
0
1
0
Order By: Relevance
“…Many studies have been done on cancer and the effects of genetic and non-genetic factors have been investigated (26)(27)(28)(29)(30)(31)(32)(33). They have also looked at several diagnostic methods (34)(35)(36)(37)(38)(39)(40). In this experiment, we investigated the value of tumor-marker joint detection in the pathological type of lung cancer.…”
Section: Comparison Of the Positive Rate Of 3 Tumor Markers In Patients With A Different Histologic Type Of Lung Cancermentioning
confidence: 99%
“…Many studies have been done on cancer and the effects of genetic and non-genetic factors have been investigated (26)(27)(28)(29)(30)(31)(32)(33). They have also looked at several diagnostic methods (34)(35)(36)(37)(38)(39)(40). In this experiment, we investigated the value of tumor-marker joint detection in the pathological type of lung cancer.…”
Section: Comparison Of the Positive Rate Of 3 Tumor Markers In Patients With A Different Histologic Type Of Lung Cancermentioning
confidence: 99%